Article Information
PubMed
Published By
History
- Received April 10, 2020
- Revision received July 9, 2020
- Accepted July 27, 2020
- Published online August 31, 2020.
Copyright & Usage
Copyright © 2020 Scheyer et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Author Information
- Andrew F. Scheyer1,2,3,
- Milene Borsoi1,2,3,
- Anne-Laure Pelissier-Alicot1,2,3,4,5 and
- Olivier J.J. Manzoni1,2,3
- 1Institut de Neurobiologie de la Méditerranée, Institut National de la Santé et de la Recherche Médicale Unité 1249, Marseille, France
- 2Aix-Marseille University, France, 13273
- 3Cannalab Cannabinoids Neuroscience Research International Associated Laboratory, Institut National de la Santé et de la Recherche Médicale-Aix-Marseille University/Indiana University, 13273
- 4Service de Psychiatrie, Assistance Public Hopitaux de Marseille, Centre Hospitalier Universitaire Conception, Marseille 13005, France
- 5Service de Médecine Légale, APHM, CHU Timone Adultes, Marseille 13005, France
- Correspondence should be addressed to Olivier J. J. Manzoni at olivier.manzoni{at}inserm.fr.
Author contributions
Author contributions: A.F.S., M.B., A.-L.P.-A., and O.J.J.M. designed research; A.F.S. and M.B. performed research; A.F.S. and M.B. analyzed data; A.F.S. and O.J.J.M. wrote the paper.
Disclosures
The authors declare no competing financial interests.
This work was supported by the Institut National de la Santé et de la Recherche Médicale (INSERM), the INSERM-National Institutes of Health (NIH) Exchange Program (A.F.S.), the Fondation pour la Recherche Médicale Grant Equipe FRM 2015 (to O.J.J.M.), and the NIH Grant R01DA043982 (to O.J.J.M.).
Funding
HHS | NIH | National Institute on Drug Abuse (NIDA)
R01DA043982Fondation pour la Recherche Médicale (FRM)
Equipe FRM 2015
Other Version
- You are viewing the most recent version of this article.
- previous version (August 31, 2020).
Online Impact
Article usage
In this issue
Maternal Exposure to the Cannabinoid Agonist WIN 55,12,2 during Lactation Induces Lasting Behavioral and Synaptic Alterations in the Rat Adult Offspring of Both Sexes
